Opioid Use After Laparoscopic Salpingectomy
Start Date
4/25/2024
Completion Date
11/1/2026
Summary
The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids. The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.
Detailed Description
This study is designed as a non-inferiority trial comparing a non-opioid post-operative pain control regimen to the standard opioid pain control regimen for post-operative salpingectomy patients. A non-inferiority margin of 2 units was selected, such that the experimental treatment will be considered non-inferior if the lower bound of the confidence interval for the treatment difference remains above a 2 point difference in reported pain scores.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Acetaminophen
Ibuprofen
Oxycodone
Conditions
Locations
Johns Hopkins Bayview Medical Center
Baltimore, Maryland 21224
United States